Clinical experience with the combined use of recombinant interleukin‐2 (IL2) and interferon alfa‐2a (IFNα) in metastatic melanoma
暂无分享,去创建一个
J. Monson | R. Stahel | A. Eggermont | R. Mertelsmann | G. Stoter | R. Bolhuis | W. Kruit | F. Calabresi | S. H. Goey | E. Holdener | P. Mulder